Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling Approaches.

Journal of Clinical Pharmacology
Anwesha ChaudhuryAndrew M Stein

Abstract

Chimeric antigen receptor T cell (CAR-T cell) therapies have shown significant efficacy in CD19+ leukemias and lymphomas. There remain many challenges and questions for improving next-generation CAR-T cell therapies, and mathematical modeling of CAR-T cells may play a role in supporting further development. In this review, we introduce a mathematical modeling taxonomy for a set of relatively simple cellular kinetic-pharmacodynamic models that describe the in vivo dynamics of CAR-T cell and their interactions with cancer cells. We then discuss potential extensions of this model to include target binding, tumor distribution, cytokine-release syndrome, immunophenotype differentiation, and genotypic heterogeneity.

References

Mar 1, 1994·Bulletin of Mathematical Biology·V A KuznetsovA S Perelson
Oct 24, 1998·Journal of Mathematical Biology·D Kirschner, J C Panetta
Apr 26, 2003·Journal of Theoretical Biology·Rustom AntiaRafi Ahmed
Mar 25, 2004·Journal of Theoretical Biology·Helen Moore, Natasha K Li
Jan 22, 2005·Nature Reviews. Immunology·Rustom AntiaRafi Ahmed
Sep 6, 2005·Cancer Research·Lisette G de PillisCharles L Wiseman
Apr 23, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Michael C MiloneCarl H June
Oct 11, 2012·PloS One·Hao Hong YiuRobert F Stengel
Jan 15, 2013·Journal of Theoretical Biology·Rob J De Boer, Alan S Perelson
Mar 16, 2013·Science·Veit R BuchholzDirk H Busch
Oct 2, 2014·Journal of Pharmacokinetics and Pharmacodynamics·Dominik Wodarz
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Jan 29, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco RuellaMariusz A Wasik
Apr 14, 2016·CPT: Pharmacometrics & Systems Pharmacology·UNKNOWN EFPIA MID3 WorkgroupS A G Visser
Apr 7, 2017·Bulletin of Mathematical Biology·Anne TalkingtonRick Durrett
Nov 17, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marco Ruella, Saad S Kenderian
Feb 22, 2018·Immunity·Stephen C Jameson, David Masopust
Mar 1, 2018·Journal for Immunotherapy of Cancer·Yuri KosinskyGabriel Helmlinger
Jun 1, 2018·Nature·Joseph A FraiettaJ Joseph Melenhorst
Sep 2, 2018·Bone Marrow Transplantation·Amir A ToorShahrukh K Hashmi
Sep 8, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen Thudium MuellerShannon L Maude
Jan 10, 2019·The Journal of Pharmacology and Experimental Therapeutics·Antari KhotDhaval K Shah
Mar 9, 2019·CPT: Pharmacometrics & Systems Pharmacology·Andrew M SteinCarl H June
Mar 10, 2019·Proceedings of the National Academy of Sciences of the United States of America·Andreas MayerNed S Wingreen
Apr 16, 2019·CPT: Pharmacometrics & Systems Pharmacology·Saroja RamanujanCraig J Thalhauser
Apr 17, 2019·Clinical and Translational Science·Deni Hardiansyah, Chee Meng Ng
Jul 5, 2019·Science Translational Medicine·Katrin MestermannMichael Hudecek
Aug 29, 2019·Nature Communications·Andrea Saltelli
Dec 18, 2019·The Journal of Clinical Investigation·Christopher L NoblesFrederic D Bushman
Jan 16, 2020·Journal of the Royal Society, Interface·Prativa SahooRussell C Rockne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.